Clinical Trial Update: Evaluation of the O'Neil Long Acting Naltrexone Implant in Opioid Dependent Persons [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the long-acting naltrexone implant for opioid use disorder is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• O'Neil Long Acting Naltrexone Implant (naltrexone implant)

Snippet

Sponsor: Go Medical Industries Pty Ltd | Conditions: Opioid Use Disorder | Phase 2 | Status: NOT_YET_RECRUITING